|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang Y, Zheng T and Zhang W: Report of
cancer incidence and mortality in China. 4:1–7. 2018.
|
|
4
|
Bomont P, Maddox P, Shah JV, Desai AB and
Cleveland DW: Unstable microtubule capture at kinetochores depleted
of the centromere-associated protein CENP-F. EMBO J. 24:3927–3939.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Varis A, Salmela AL and Kallio MJ: Cenp-F
(mitosin) is more than a mitotic marker. Chromosoma. 115:288–295.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liao H, Winkfein RJ, Mack G, Rattner JB
and Yen TJ: CENP-F is a protein of the nuclear matrix that
assembles onto kinetochores at late G2 and is rapidly degraded
after mitosis. J Cell Biol. 130:507–518. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Clark GM, Allred DC, Hilsenbeck SG,
Chamness GC, Osborne CK, Jones D and Lee WH: Mitosin (a new
proliferation marker) correlates with clinical outcome in
node-negative breast cancer. Cancer Res. 57:5505–5508.
1997.PubMed/NCBI
|
|
8
|
de la Guardia C, Casiano CA,
Trinidad-Pinedo J and Báez A: CENP-F gene amplification and
overexpression in head and neck squamous cell carcinomas. Head
Neck. 23:104–112. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim HE, Kim DG, Lee KJ, Son JG, Song MY,
Park YM, Kim JJ, Cho SW, Chi SG, Cheong HS, et al: Frequent
amplification of CENPF, GMNN and CDK13 genes in hepatocellular
carcinomas. PLoS One. 7:e432232012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
O'Brien SL, Fagan A, Fox EJ, Millikan RC,
Culhane AC, Brennan DJ, McCann AH, Hegarty S, Moyna S, Duffy MJ, et
al: CENP-F expression is associated with poor prognosis and
chromosomal instability in patients with primary breast cancer. Int
J Cancer. 120:1434–1443. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shahid M, Lee MY, Piplani H, Andres AM,
Zhou B, Yeon A, Kim M, Kim HL and Kim J: Centromere protein F
(CENPF), a microtubule binding protein, modulates cancer metabolism
by regulating pyruvate kinase M2 phosphorylation signaling. Cell
Cycle. 17:2802–2818. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li P, You S, Nguyen C, Wang Y, Kim J,
Sirohi D, Ziembiec A, Luthringer D, Lin SC, Daskivich T, et al:
Genes involved in prostate cancer progression determine MRI
visibility. Theranostics. 8:1752–1765. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang IC, Snyder J, Zhang Y, Lander J,
Nakafuku Y, Lin J, Chen G, Kalin TV, Whitsett JA and Kalinichenko
VV: Foxm1 mediates cross talk between Kras/mitogen-activated
protein kinase and canonical Wnt pathways during development of
respiratory epithelium. Mol Cell Biol. 32:3838–3850. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bolte C, Zhang Y, Wang I-C, Kalin TV,
Molkentin JD and Kalinichenko VV: Expression of Foxm1 transcription
factor in cardiomyocytes is required for myocardial development.
PLoS One. 6:e222172011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ustiyan V, Wert SE, Ikegami M, Wang IC,
Kalin TV, Whitsett JA and Kalinichenko VV: Foxm1 transcription
factor is critical for proliferation and differentiation of Clara
cells during development of conducting airways. Dev Biol.
370:198–212. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim I-M, Ramakrishna S, Gusarova GA, Yoder
HM, Costa RH and Kalinichenko VV: The forkhead box m1 transcription
factor is essential for embryonic development of pulmonary
vasculature. J Biol Chem. 280:22278–22286. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zeng J, Wang L, Li Q, Li W, Björkholm M,
Jia J and Xu D: FoxM1 is up-regulated in gastric cancer and its
inhibition leads to cellular senescence, partially dependent on p27
kip1. J Pathol. 218:419–427. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang C, Chen H, Tan G, Gao W, Cheng L,
Jiang X, Yu L and Tan Y: FOXM1 promotes the epithelial to
mesenchymal transition by stimulating the transcription of Slug in
human breast cancer. Cancer Lett. 340:104–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Z, Ahmad A, Li Y, Banerjee S, Kong D
and Sarkar FH: Forkhead box M1 transcription factor: A novel target
for cancer therapy. Cancer Treat Rev. 36:151–156. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu M, Dai B, Kang S-H, Ban K, Huang FJ,
Lang FF, Aldape KD, Xie TX, Pelloski CE, Xie K, et al: FoxM1B is
overexpressed in human glioblastomas and critically regulates the
tumorigenicity of glioma cells. Cancer Res. 66:3593–3602. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim I-M, Ackerson T, Ramakrishna S,
Tretiakova M, Wang IC, Kalin TV, Major ML, Gusarova GA, Yoder HM,
Costa RH, et al: The Forkhead Box m1 transcription factor
stimulates the proliferation of tumor cells during development of
lung cancer. Cancer Res. 66:2153–2161. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu N, Jia D, Chen W, Wang H, Liu F, Ge H,
Zhu X, Song Y, Zhang X, Zhang D, et al: FoxM1 is associated with
poor prognosis of non-small cell lung cancer patients through
promoting tumor metastasis. PLoS One. 8:e594122013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang DK, Son CH, Lee SK, Choi PJ, Lee KE
and Roh MS: Forkhead box M1 expression in pulmonary squamous cell
carcinoma: Correlation with clinicopathologic features and its
prognostic significance. Hum Pathol. 40:464–470. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Aytes A, Mitrofanova A, Lefebvre C,
Alvarez MJ, Castillo-Martin M, Zheng T, Eastham JA, Gopalan A,
Pienta KJ, Shen MM, et al: Cross-species regulatory network
analysis identifies a synergistic interaction between FOXM1 and
CENPF that drives prostate cancer malignancy. Cancer Cell.
25:638–651. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin SC, Kao CY, Lee HJ, Creighton CJ,
Ittmann MM, Tsai SJ, Tsai SY and Tsai MJ: Dysregulation of
miRNAs-COUP-TFII-FOXM1-CENPF axis contributes to the metastasis of
prostate cancer. Nat Commun. 7:114182016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lokody I: Signalling: FOXM1 and CENPF:
co-pilots driving prostate cancer. Nat Rev Cancer. 14:450–451.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee JJ, Maeng CH, Baek SK, Kim GY, Yoo JH,
Choi CW, Kim YH, Kwak YT, Kim DH, Lee YK, et al: The
immunohistochemical overexpression of ribonucleotide reductase
regulatory subunit M1 (RRM1) protein is a predictor of shorter
survival to gemcitabine-based chemotherapy in advanced non-small
cell lung cancer (NSCLC). Lung Cancer. 70:205–210. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mizuno K, Mataki H, Arai T, Okato A,
Kamikawaji K, Kumamoto T, Hiraki T, Hatanaka K, Inoue H and Seki N:
The microRNA expression signature of small cell lung cancer: Tumor
suppressors of miR-27a-5p and miR-34b-3p and their targeted
oncogenes. J Hum Genet. 62:671–678. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma J, Qi G, Xu J, et al: Overexpression of
forkhead box m1 and urokinase-type plasminogen activator in gastric
cancer is associated with cancer progression and poor prognosis.
Oncol Lett. 14:7288–7296. 2017.PubMed/NCBI
|
